EPA Proposed Research Rules Leaked Thu Aug 11, 2005 A storm is gathering as EPA’s proposed rules for human pesticide experiments have been made public by the Public Employees for Environmental Responsibility. Stephen Johnson who heads the EPA has delivered what, Eric Olson called, a “slap in the face” to…
Bayh-Dole Act: The Law of Unintended Consequences – Fortune Sun, 25 Sep 2005 The author of this Infomail is Dianne N. Irving, M.A., Ph.D. Revisiting the Bayh-Dole Act (1980): Spawned Big Biotech, Now Has Opposite Debilitating Effects Today’s specter of harmful and inordinately priced drugs pressed on legislators and the…
Calls Mounting for FDA Revamp / Americans Are the most medicated population in the world – DHHS Sun, 26 Dec 2004 A government survey by the U.S. Department of Health and Human Services, confirms that Americans are the most medicated population in the world – 44 percent of Americans had…
Medicaid Battles: Law firm With Ties to Drug Makers Joins Fight in Tennessee / NYT Blind Spot Mon, 14 Mar 2005 The Tennessean reports: “An international law firm with ties to major drug manufacturers is providing free legal help to the advocacy group seeking to block the state from cutting…
US Gov Pesticide Exposure Experiments: Target Children–$970 per child – Wash Post Wed, 3 Nov 2004 The Washington Post reports (below) that the Environmental Protection Agency (EPA) announced plans to enroll 60 young children in Duval County, Florida – infants to age 3 – exposing them to pesticides to study…
Cholesterol lowering drug, Crestor Linked to Patient Death Tue, 11 Jan 2005 Crestor, a highly advertised cholesterol-lowering drug in the statin class–as was Bayer’s drug Baycol, which was withdrawn from market after 30 patients died of rhabdomyolysis (breakdown of skeletal muscle fibers), has been linked to a patient’s death. “AstraZeneca…
Conflicts of Interest policy – New York Times Sun, 28 Mar 2004 To: ‘Executive-editor@nytimes’; ‘gcollins@nytimes’; ‘arosenthal@nytimes’; ‘pboffey@nytimes’; ‘lchang@nytimes’; ‘oped@nytimes’ Cc: ‘Daniel Okrent’ ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting openness and full disclosure https://ahrp.org FYI Friday’s New York Times included the following Editor’s Note on the paper’s Op Ed page:…
AHRP Speaks Out AHRP Press Briefing 9/14/04: Antidepressants & suicide-related risks for children Open Letter to NIMH re Prozac & Concealed Suicide Attempts Open Letter to Officials at NIMH AHRP Briefing 2/2/04: Scientists present suicide evidence Conflicts of Interest policy – New York Times Phase I Drug Trials Used Foster…
Is Tamiflu worth it? Thu, 27 Oct 2005 Many knowledgable experts in pharmacology have expressed dismay over the hysteria mounting for Tamiflu, a drug that has shown to be only marginally effective at best in reducing ther number of days one experinces flu symptoms. In elderly patients who are at…
FDA issued an advisory stating that the concealed study results demonstrate "that use of Trasylol may increase the chance for death, serious kidney damage, congestive heart failure and strokes."
The pharmaceutical industry seems to be predisposed to corporate crime– much as the Mafia is–it’s their way of doing business.
An editorial in today's New York Times is a follow-up to its riveting report by Ian Urbina on the recommendation by an Institute of Medicine panel to
lift 1978 federal restrictions on medical experiments on prisoners. http://www.nytimes.com/2006/08/13/us/13inmates.html?
